Table 2 Correlation between GOLPH3 expression and clinicopathologic characteristics of patients with clinically N0 oral tongue cancer
Characteristics | n | GOLPH3 expression | χ2testP | |
|---|---|---|---|---|
Low or none, no. (%) | High, no. (%) | (Fisher’s exact testP) | ||
Gender | 0.574 | |||
Male | 109 | 33 (30.3) | 76 (69.7) | |
Female | 70 | 24 (34.3) | 46 (65.7) | |
Age (years) | 0.594 | |||
< 53 | 89 | 30 (33.7) | 59 (66.3) | |
≥ 53 | 90 | 27 (30.0) | 63 (70.0) | |
clinical stage | 0.001 | |||
I | 80 | 39 (48.8) | 41 (51.2) | |
II | 67 | 14 (20.9) | 53 (79.1) | |
III | 17 | 1 (5.9) | 16 (94.1) | |
IV | 15 | 3 (20) | 12 (80) | |
T classification | 0.001 | |||
T1 | 87 | 39 (44.8) | 48 (55.2) | |
T2 | 87 | 16 (18.4) | 71 (81.6) | |
T3 | 5 | 2 (40.0) | 3 (60.0) | |
N classification | 0.043 | |||
N0 | 149 | 53 (35.6) | 96 (64.4) | |
N1 | 15 | 1 (6.7) | 14 (93.3) | |
N2 | 15 | 3 (20.0) | 12 (80.0) | |
Pathologic differentiation | 0.338 | |||
Well | 136 | 46 (33.3) | 90 (66.7) | |
Moderately | 36 | 8 (22.2) | 28 (77.8) | |
Poorly | 7 | 3 (42.9) | 4 (57.1) | |
Recurrence | 0.009 | |||
No | 120 | 45 (37.5) | 75 (62.5) | |
Yes | 59 | 11 (18.6) | 48 (81.4) | |
Vital status (at follow-up) | 0.010 | |||
Alive | 122 | 46 (37.8) | 76 (62.2) | |
Dead | 57 | 11 (19.3) | 46 (80.7) | |